FDA places clinical hold on Merck's combo therapy for multiple myeloma

(Reuters) - Merck & Co Inc said on Wednesday the U.S. Food and Drug Administration had placed a clinical hold on three multiple myeloma studies testing its immunotherapy drug, Keytruda, in combination with other therapies.